Emcure Pharmaceuticals Limited (NSE:EMCURE)
1,550.60
+51.50 (3.44%)
At close: Jan 13, 2026
14.19% (1Y)
| Market Cap | 293.95B |
| Revenue (ttm) | 84.49B |
| Net Income (ttm) | 7.93B |
| Shares Out | 189.57M |
| EPS (ttm) | 41.87 |
| PE Ratio | 37.03 |
| Forward PE | 28.52 |
| Dividend | 3.00 (0.20%) |
| Ex-Dividend Date | Aug 14, 2025 |
| Volume | 480,362 |
| Average Volume | 207,706 |
| Open | 1,510.40 |
| Previous Close | 1,499.10 |
| Day's Range | 1,495.50 - 1,557.20 |
| 52-Week Range | 889.00 - 1,568.30 |
| Beta | n/a |
| RSI | 65.79 |
| Earnings Date | Feb 10, 2026 |